Skip to main content
Retour
Watch Compare

GOLDENWELL BIOTECH, INC.

Qualité des données : 100%
GWLL
OTC Manufacturing Food Products
1,00 €
▼ 0,00 € (-0,35%)
6 months return
—
Momentum
Neutral
Net margin
22481,65%

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)-94,06%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROIC-25,94%
Net Margin22481,65%
Op. Margin38238,61%

Sécurité

Debt / Equity
N/A
Current RatioN/A
Interest Coverage-4,11

Valorisation

PE (TTM)
-2796,84
En dessous de la moyenne du secteur (-1,50)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Net margin of 22481,65% shows strong profitability
Negative free cash flow of -22 832,0

Price History

Tendances Financières

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) -94,06% Revenue Growth (3Y) -94,61%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: N/A · Net Margin: 22481,65%
Revenue (TTM) -158,0 Net Income (TTM) -35 521,0
ROE N/A ROA -15,06%
Gross Margin -39503,16% Operating Margin 38238,61%
Net Margin 22481,65% Free Cash Flow (TTM) -22 832,0
ROIC -25,94% FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: N/A
Debt / Equity N/A Current Ratio N/A
Interest Coverage -4,11 Asset Turnover 0,00
Working Capital N/A Tangible Book Value -94 823

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -2796,84 · EV/EBITDA: N/A
P/E Ratio -2796,84 Forward P/E N/A
P/B Ratio N/A P/S Ratio -628775,29
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -0,02%
Market Cap 99,35 M Enterprise Value 99,35 M

Per Share

EPS: 0,00 · FCF/Share: 0,00
EPS (Diluted TTM) 0,00 Revenue / Share 0,00
FCF / Share 0,00 OCF / Share 0,00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 64,28% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 64,28%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 139,0 2 340,0 47 800,0 15 967,0 0,0
Net Income -131 498,0 -116 895,0 -985 097,0 -116 981,0 -6 324,0
EPS (Diluted) 0,00 — — — —
Gross Profit 64,0 1 108,0 25 186,0 8 388,0 0,0
Operating Income -123 098,0 -116 895,0 -985 105,0 — —
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — 126 655,0 6 368,0
D&A — — — — —
Interest Expense 8 400,0 — — 0,0 0,0
Income Tax 0,0 0,0 0,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 224 192,0 228 057,0 248 400,0 460 979,0 248 569,0
Total Liabilities 271 433,0 143 334,0 46 782,0 159 266,0 0,0
Shareholders' Equity -47 241,0 84 723,0 201 618,0 301 713,0 248 569,0
Total Debt 173 985,0 — — — —
Cash & Equivalents — — 45 996,0 213 556,0 248 569,0
Current Assets — — — — —
Current Liabilities — — — 159 266,0 0,0

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1605 pairs)
Métrique Action Médiane du Secteur
P/E -2796,8 -1,5
P/B — 1,6
ROE % — -54,5
Net Margin % 22481,7 -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3